The world's first self-amplifying mRNA vaccine, or replicon vaccine, was administered in Japan to prevent SARS-CoV-2 infection.1 Similar to other infodemics related to COVID-19 vaccines,2 ...

Researchers from City St George’s, University of London are calling for more research to confirm whether the increase in ...

We tend to think of COVID-19 as a respiratory illness. But, like many viruses, COVID can also affect your skin and cause ...

A study published in Obstetrics and Gynecology looks at heart defects in babies during the Covid-19 pandemic. Prof Kevin McConway, Emeritus Professor of Applied Statistics, Open University, said: ...

Aspen Group (ASX:APZ) has upgraded its earnings guidance for FY25. The company now expects underlying earnings per security to reach 16.0 cents, a 5% increase over previous forecasts and a 16% rise ...

Opthea (ASX:OPT) has announced a boost to its cash reserves, receiving a $15.9m research and development tax incentive from ...